We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+47.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$105M
AUM Growth
+$33.6M
Cap. Flow
+$708K
Cap. Flow %
0.68%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
FSNN
Fusion Connect, Inc. Common Stock
FSNN
+$708K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.6%
2 Communication Services 19.89%
3 Industrials 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
1
Tvardi Therapeutics
TVRD
$23.6M
$68.3M 65.36%
99,113
LVO icon
2
LiveOne
LVO
$68.9M
$20.8M 19.89%
360,294
MRSN
3
DELISTED
Mersana Therapeutics
MRSN
$14.2M 13.61%
31,858
SENS icon
4
Senseonics Holdings Inc
SENS
$257M
$656K 0.63%
7,980
FSNN
5
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$541K 0.52%
+155,069
New +$708K

Similar funds

Rho Capital Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Rho Capital Partners held 5 positions worth $105M, up 47% from $70.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners's Q2 2018 filing shows 1 new position. Its largest new stake was Fusion Connect, Inc. Common Stock: 155,069 shares worth $541K.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 81% a quarter earlier, followed by Communication Services and Industrials.

  • Rho Capital Partners's largest Q2 2018 buy was Fusion Connect, Inc. Common Stock: 155,069 shares worth $541K.
  • Rho Capital Partners's ten largest holdings make up 100% of its $105M portfolio in Q2 2018.
  • Rho Capital Partners opened 1 new position and closed 0 in Q2 2018.
  • Rho Capital Partners's portfolio value rose 47% quarter-over-quarter to $105M.

Based on Rho Capital Partners's 13F filing for Q2 2018, filed 13 Aug 2018.